Research Article
Polymorphisms of β1-Adrenoreceptor Gene and Cardiovascular Complications in Patients with Thyrotoxicosis
Table 5
Genotype and allele distribution for Ser49Gly polymorphism in patients with Graves’ disease and control group.
| | Group | | | % | Allele frequency |
| | Patients with thyrotoxicosis, | GG (Gly49Gly) | 9 | 5.5 |
G—0.22
A—0.78 | | AG (Ser49Gly) | 56 | 33.9 | | AA (Ser49Ser) | 100 | 60.6 |
| | Control group, | GG (Gly49Gly) | 2 | 2 |
G—0.17
A—0.83 | | AG (Ser49Gly) | 31 | 30.7 | | AA (Ser49Ser) | 68 | 67.3 |
|
|
